NAIROBI, Kenya — In many African cultures, a big belly has long been seen as a sign of wealth. But this perception is proving ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

Not all children grow the same way. A new study from the Environmental influences on Child Health Outcomes (ECHO) Program ...

The 70-page report from the Make America Healthy Again Commission targets the pharmaceutical and food industries for growing rates of childhood chronic disease.

Wegovy belongs to a pricey class of drugs called GLP-1s (short for glucagon-like peptide-1 agonists) that have upended the ...

CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

Patients taking Eli Lilly’s drug to combat obesity, Zepbound, lost more weight than those who took Novo Nordisk’s Wegovy in a ...

A looming health crisis is threatening teenagers, with nearly half a billion projected to be overweight or obese by 2030, according to a new report.